首页 > 最新文献

Cancer Research, Statistics, and Treatment最新文献

英文 中文
First ray of dawn to full-blown sunshine: Journey of a research scholar 第一缕曙光到全面的阳光:一个研究学者的旅程
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_88_23
S. Singhal, A. Parekh, M. Verma
{"title":"First ray of dawn to full-blown sunshine: Journey of a research scholar","authors":"S. Singhal, A. Parekh, M. Verma","doi":"10.4103/crst.crst_88_23","DOIUrl":"https://doi.org/10.4103/crst.crst_88_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"38 1","pages":"179 - 180"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86547236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' reply to Gurushankari and Kate, and Patil 作者对Gurushankari、Kate和Patil的回复
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_181_23
N. Kurian, E. Mathew
{"title":"Authors' reply to Gurushankari and Kate, and Patil","authors":"N. Kurian, E. Mathew","doi":"10.4103/crst.crst_181_23","DOIUrl":"https://doi.org/10.4103/crst.crst_181_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"100 1","pages":"329 - 330"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76264416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rucaparib in metastatic prostate cancer 鲁卡帕尼治疗转移性前列腺癌
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_131_23
Praful Pandey, A. Gogia
{"title":"Rucaparib in metastatic prostate cancer","authors":"Praful Pandey, A. Gogia","doi":"10.4103/crst.crst_131_23","DOIUrl":"https://doi.org/10.4103/crst.crst_131_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"55 29 1","pages":"360 - 361"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73791530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carcinoma cervix with scalp metastasis: An unusual case report 宫颈癌合并头皮转移1例
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_25_23
Somya Sharma, Pragati Kesharwani, Amresh Kumar, Ashar Lodi, V. Bhandari
{"title":"Carcinoma cervix with scalp metastasis: An unusual case report","authors":"Somya Sharma, Pragati Kesharwani, Amresh Kumar, Ashar Lodi, V. Bhandari","doi":"10.4103/crst.crst_25_23","DOIUrl":"https://doi.org/10.4103/crst.crst_25_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"34 6","pages":"353 - 356"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72414616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation-induced esophagitis in patients with breast cancer receiving supraclavicular nodal irradiation: A retrospective observational study 接受锁骨上淋巴结照射的乳腺癌患者的放射性诱导食管炎:一项回顾性观察研究
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_10_23
Zalfa A. Azeez, D. Fernandes, Sandesh Rao, H. Krishnaraj, T. Jacob, Lanisha Sequeira
Background: Radiotherapy is an important treatment modality for locally advanced breast cancer and includes irradiation of the chest wall and supraclavicular nodes, with or without the axilla. Since the esophagus is close to the supraclavicular nodes, patients may experience acute radiation esophagitis during treatment which decreases their quality of life. Objective: To identify the dosimetric parameters of the esophagus which may affect the occurrence of esophagitis in patients with breast cancer who received supraclavicular nodal irradiation. Materials and Methods: This was a single-center retrospective observational study carried out from January 2021 to June 2022 at Father Muller Medical College Hospital, Mangalore, India. We enrolled patients with histologically proven breast cancer, who had received post-mastectomy radiation to the chest wall and supraclavicular nodes to a dose of 50 Gy in 25 fractions, 2 Gy per fraction, 5 fractions per week with 6 MV photon linear accelerator by intensity modulated radiation therapy. Toxicities were recorded every week. The parameters documented included the mean esophageal dose, maximum dose to the esophagus, and length of the esophagus within the treatment area. Results: We enrolled 25 patients with infiltrating ductal carcinoma of the breast who had undergone mastectomy and received neoadjuvant or adjuvant chemotherapy. The median age was 53 years (IQR, 44.5-63.5). Esophagitis (any grade) was noted in 18 of the 25 patients (72%). Grade 2 esophagitis developed in all 6 patients (100%) who had received a mean esophageal dose >20 Gy, and in none of the 19 (0%) who received a dose <20 Gy; P < 0.001. The development of esophagitis was not significantly associated with the esophageal length included in the treating area (P = 0.62), the maximum dose to the esophagus (P = 0.09), V10 (P = 0.49), or V20 (P = 1). The esophageal mean dose (Dmean) was the sole predictive factor for the development of esophagitis; P = 0.04. Conclusion: In patients with breast cancer receiving post-mastectomy radiation to the chest wall and supraclavicular area, the mean esophageal radiation dose is the only factor that correlates with the development of esophageal toxicity. Thus, esophageal toxicity can be reduced by prescribing dose constraints to the esophagus, thereby potentially improving the quality of life of patients.
背景:放射治疗是局部晚期乳腺癌的重要治疗方式,包括胸壁和锁骨上淋巴结的放射治疗,有或没有腋窝。由于食管靠近锁骨上淋巴结,患者在治疗期间可能出现急性放射性食管炎,从而降低其生活质量。目的:探讨可能影响乳腺癌锁骨上淋巴结照射患者食管炎发生的食道剂量学参数。材料和方法:这是一项单中心回顾性观察性研究,于2021年1月至2022年6月在印度芒格洛尔的穆勒神父医学院医院进行。我们招募了组织学证实的乳腺癌患者,他们接受了乳房切除术后胸壁和锁骨上淋巴结的放射治疗,剂量为50 Gy,分25次,每次2 Gy,每周5次,使用6 MV光子线性加速器进行强度调制放射治疗。每周记录毒性。记录的参数包括平均食道剂量、食道最大剂量和治疗区域内食道长度。结果:我们纳入了25例乳腺浸润性导管癌患者,均行乳房切除术并接受新辅助或辅助化疗。中位年龄53岁(IQR, 44.5-63.5)。25例患者中有18例(72%)出现食管炎(任何级别)。接受平均食道剂量>20 Gy的6例患者(100%)均发生2级食管炎,接受剂量<20 Gy的19例患者(0%)均未发生2级食管炎;P < 0.001。食管炎的发生与治疗区食管长度(P = 0.62)、食管最大剂量(P = 0.09)、V10 (P = 0.49)、V20 (P = 1)无显著相关性,食管平均剂量(Dmean)是食管炎发生的唯一预测因素;P = 0.04。结论:乳腺癌患者行乳房切除术后胸壁及锁骨上区放射治疗,食道平均放射剂量是影响食道毒性发生的唯一因素。因此,可以通过限制食道剂量来减少食道毒性,从而潜在地改善患者的生活质量。
{"title":"Radiation-induced esophagitis in patients with breast cancer receiving supraclavicular nodal irradiation: A retrospective observational study","authors":"Zalfa A. Azeez, D. Fernandes, Sandesh Rao, H. Krishnaraj, T. Jacob, Lanisha Sequeira","doi":"10.4103/crst.crst_10_23","DOIUrl":"https://doi.org/10.4103/crst.crst_10_23","url":null,"abstract":"Background: Radiotherapy is an important treatment modality for locally advanced breast cancer and includes irradiation of the chest wall and supraclavicular nodes, with or without the axilla. Since the esophagus is close to the supraclavicular nodes, patients may experience acute radiation esophagitis during treatment which decreases their quality of life. Objective: To identify the dosimetric parameters of the esophagus which may affect the occurrence of esophagitis in patients with breast cancer who received supraclavicular nodal irradiation. Materials and Methods: This was a single-center retrospective observational study carried out from January 2021 to June 2022 at Father Muller Medical College Hospital, Mangalore, India. We enrolled patients with histologically proven breast cancer, who had received post-mastectomy radiation to the chest wall and supraclavicular nodes to a dose of 50 Gy in 25 fractions, 2 Gy per fraction, 5 fractions per week with 6 MV photon linear accelerator by intensity modulated radiation therapy. Toxicities were recorded every week. The parameters documented included the mean esophageal dose, maximum dose to the esophagus, and length of the esophagus within the treatment area. Results: We enrolled 25 patients with infiltrating ductal carcinoma of the breast who had undergone mastectomy and received neoadjuvant or adjuvant chemotherapy. The median age was 53 years (IQR, 44.5-63.5). Esophagitis (any grade) was noted in 18 of the 25 patients (72%). Grade 2 esophagitis developed in all 6 patients (100%) who had received a mean esophageal dose >20 Gy, and in none of the 19 (0%) who received a dose <20 Gy; P < 0.001. The development of esophagitis was not significantly associated with the esophageal length included in the treating area (P = 0.62), the maximum dose to the esophagus (P = 0.09), V10 (P = 0.49), or V20 (P = 1). The esophageal mean dose (Dmean) was the sole predictive factor for the development of esophagitis; P = 0.04. Conclusion: In patients with breast cancer receiving post-mastectomy radiation to the chest wall and supraclavicular area, the mean esophageal radiation dose is the only factor that correlates with the development of esophageal toxicity. Thus, esophageal toxicity can be reduced by prescribing dose constraints to the esophagus, thereby potentially improving the quality of life of patients.","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"37 1","pages":"209 - 214"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77905071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Somewhere over the rainbow: Love is love 彩虹之上的某处:爱就是爱
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_188_23
Prasad R. Dandekar, Gargi Mhatre, R. Das
{"title":"Somewhere over the rainbow: Love is love","authors":"Prasad R. Dandekar, Gargi Mhatre, R. Das","doi":"10.4103/crst.crst_188_23","DOIUrl":"https://doi.org/10.4103/crst.crst_188_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"119 1","pages":"175 - 178"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79407653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caregiving: A loving burden 照顾:爱的负担
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_72_23
Vandana N. Mahajan
{"title":"Caregiving: A loving burden","authors":"Vandana N. Mahajan","doi":"10.4103/crst.crst_72_23","DOIUrl":"https://doi.org/10.4103/crst.crst_72_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"2 3","pages":"302 - 304"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72474584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low number of transgender persons with cancer: A survey assessment of the Indian scenario 患癌症的跨性别者人数少:对印度情况的调查评估
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_136_23
Biplab Sarkar, Anirudh Pradhan
{"title":"Low number of transgender persons with cancer: A survey assessment of the Indian scenario","authors":"Biplab Sarkar, Anirudh Pradhan","doi":"10.4103/crst.crst_136_23","DOIUrl":"https://doi.org/10.4103/crst.crst_136_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"11 1","pages":"235 - 238"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75375935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reporting rectal dose in pelvic radiotherapy: Valid or virtual? 盆腔放疗报告直肠剂量:有效还是虚假?
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_101_23
C. Waghmare
{"title":"Reporting rectal dose in pelvic radiotherapy: Valid or virtual?","authors":"C. Waghmare","doi":"10.4103/crst.crst_101_23","DOIUrl":"https://doi.org/10.4103/crst.crst_101_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"11 1","pages":"315 - 317"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88399844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ChatGPT in the Indian healthcare scenario: Look before you leap ChatGPT在印度医疗保健领域:三思而后行
Q1 Medicine Pub Date : 2023-04-01 DOI: 10.4103/crst.crst_161_23
Divya Gupta, J. Mahadevan
{"title":"ChatGPT in the Indian healthcare scenario: Look before you leap","authors":"Divya Gupta, J. Mahadevan","doi":"10.4103/crst.crst_161_23","DOIUrl":"https://doi.org/10.4103/crst.crst_161_23","url":null,"abstract":"","PeriodicalId":9427,"journal":{"name":"Cancer Research, Statistics, and Treatment","volume":"34 1","pages":"337 - 338"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90818454","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Cancer Research, Statistics, and Treatment
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1